Yongxiang Xia

7PUBLICATIONS
18CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyGenome structure and regulationMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 14, 2026
CRISPR/Cas9 screen identifies DCAF4 as a novel protector of hepatocellular carcinoma against brachytherapy via stress granule-dependent NRF2 activation.

|Jun 12, 2024
MAL2 reprograms lipid metabolism in intrahepatic cholangiocarcinoma via EGFR/SREBP-1 pathway based on single-cell RNA sequencing.

Tian Huang, Hengsong Cao, Chuan Liu

|Nov 25, 2023
Single-cell RNA-sequencing atlas reveals an FABP1-dependent immunosuppressive environment in hepatocellular carcinoma.

Weiwei Tang, Guangshun Sun, Gu-Wei Ji

|Feb 14, 2023
GLIS1 intervention enhances anti-PD1 therapy for hepatocellular carcinoma by targeting SGK1-STAT3-PD1 pathway.

Dawei Rong, Yuliang Wang, Li Liu

|Jan 05, 2023
Macrophage GSK3β-deficiency inhibits the progression of hepatocellular carcinoma and enhances the sensitivity of anti-PD1 immunotherapy.

Guangshun Sun, Hanyuan Liu, Jie Zhao

|Dec 12, 2022
PRDM1/BLIMP1 induces cancer immune evasion by modulating the USP22-SPI1-PD-L1 axis in hepatocellular carcinoma cells.

Qing Li, Liren Zhang, Wenhua You

Pageof 2

Frequent Collaborators

5 joint publications

Weiwei Tang

2 joint publications

Xuehao Wang

1 joint publications

Sun Guangshun

1 joint publications

Sun Guoqiang